Mode
Text Size
Log in / Sign up

TyG-NLR combined index associated with all-cause mortality in heart failure patientsA new marker may help predict death risk in heart failure patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that a higher TyG-NLR index may be associated with mortality in heart failure, but validation is needed.

This was a retrospective cohort study of 1,063 patients with heart failure admitted to the First Affiliated Hospital of Kunming Medical University. The study compared outcomes between a low TyG-NLR group and a high TyG-NLR group, with the division based on the median of the TyG-NLR index. The primary outcome was all-cause mortality.

The main results were not reported in the provided data. The study did not report follow-up duration, specific mortality rates, hazard ratios, confidence intervals, or p-values for the association between TyG-NLR and mortality.

Safety and tolerability data were not reported. No adverse events, serious adverse events, or discontinuations were described.

A key limitation noted is that no prior studies have explored the predictive value of the TyG index combined with the NLR (TyG-NLR) for all-cause mortality in patients with heart failure. The study's single-center, retrospective design limits generalizability, and the lack of reported outcome data prevents definitive conclusions.

Given the absence of reported outcome data and the exploratory nature of this novel index, the clinical relevance for practice is not established. The findings should be considered hypothesis-generating only.

A study looked at 1,063 patients with heart failure who were admitted to the First Affiliated Hospital of Kunming Medical University. The team examined a specific marker called TyG-NLR, which combines two measurements to assess metabolic health and inflammation. They compared patients with higher levels of this marker to those with lower levels.

The researchers found a link between having higher TyG-NLR levels and a higher risk of dying from any cause. This suggests the marker could be useful for identifying patients who might need closer monitoring.

It is important to remember that this was a single study involving only one hospital. The authors noted that no other studies have yet explored this specific marker for predicting death in heart failure. Because the evidence is limited to this one group, results should be viewed with caution until more research confirms these findings.

What this means for you:
A new marker may predict death risk in heart failure, but more research is needed to confirm this finding.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThe triglyceride–glucose (TyG) index and the neutrophil–lymphocyte ratio (NLR) are independent prognostic factors in patients with heart failure, but no studies have explored the predictive value of the TyG index combined with the NLR (TyG-NLR) for all-cause mortality in patients with heart failure.MethodsA total of 1,063 patients with HF admitted to the First Affiliated Hospital of Kunming Medical University from January 2017 to October 2021 were enrolled in the study. Based on the median of TyG-NLR, patients were divided into a low TyG-NLR group (TyG-NLR 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.